Connection

Ian Douglas to Muscarinic Antagonists

Back to Details
This is a "connection" page, showing publications Ian Douglas has written about Muscarinic Antagonists.
Ian Douglas
Connection Strength
0.089
Muscarinic Antagonists
  1. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020 11; 8(11):1106-1120.
    View in: PubMed
    Score: 0.046
  2. Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax. 2019 11; 74(11):1078-1086.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.